XDWH:F:F-Xtrackers (IE) Public Limited Company - Xtrackers MSCI World Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 51.28

Change

-0.33 (-0.64)%

Market Cap

USD 2.60B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.18 (-0.65%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.34 (-0.66%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.22 (-0.22%)

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.32 (-0.57%)

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.95 (-0.40%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.10 (-0.64%)

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.09 (-0.09%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.23%)

USD 40.74B
0ZC:F Zscaler Inc

+5.22 (+3.51%)

USD 37.92B

ETFs Containing XDWH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.41% 66% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.41% 63% D 57% F
Trailing 12 Months  
Capital Gain 14.72% 48% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.72% 44% F 50% F
Trailing 5 Years  
Capital Gain 70.54% 82% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 70.54% 82% B 63% D
Average Annual (5 Year Horizon)  
Capital Gain 10.14% N/A N/A 70% C-
Dividend Return 10.14% N/A N/A 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.93% N/A N/A 90% A-
Risk Adjusted Return 113.56% N/A N/A 98% N/A
Market Capitalization 2.60B 87% B+ 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike